General
Reccomendations for HAN Flu Vaccinations
On August 31, 2022, the FDA authorized emergency use of new bivalent formulations of both the Moderna COVID-19 and the Pfizer-BioNTech COVID-19 Vaccines for use as a single booster dose at least two months following primary or booster vaccination.
As of August 8, 2022, the Centers for Disease Control and Prevention (CDC) and state and local public health departments are reporting 8934 confirmed and probable cases of monkeypox in the United States across 49 states, Washington D.C., and Puerto Rico
Paxlovid is a highly effective treatment against COVID-19. In clinical trials, Paxlovid was shown to have an 88% reduction in hospitalization and death.
Monkeypox Virus Infection in the United States and Other Non-endemic Countries - 07/08/2022
New Mexico Department of Health (NMDOH) Marks the End of the 2021-2022 Influenza Season
Measles Case in Santa Fe County, NM
COVID-19 Therapeutics Update: Patient Issuance of COVID-19 Therapeutic within Therapeutic Window - 05/26/2022
Monkeypox Virus Infection in the United States and Other Non-endemic Countries - 05/26/2022
Updated Booster Guidance - 05/22/2022
Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology - 04/21/2022
COVID-19 Vaccination Rule 3
COVID-19 Vaccination and Treatment During Pregnancy
COVID-19 Vaccination and Treatment During Pregnancy - 04-07-2022
Joint Statement on COVID-19 Vaccination and Treatment During Pregnancy - 04-06-2022
COVID-19 Therapeutics Update - 04/05/2022
COVID-19 Therapeutics Update: Sotrovimab Pause & Updated NIH Treatment Guidelines - 04-05-2022
COVID Therapeutics - Quick Reference for Prescribers - 04-05-2022
HAN Alert Pediatric Ingestion of Cannabis Products
HAN Alert COVID-19 2nd Booster Dose Guidance
All 2021 HAN Alerts
Registration Guide Dec 2016, Cipro Resistant Meningitidis - 08-06-2020, Remdesivir Update Guidance - 08-28 2020, COVID-19 Pre-Season - 09-11-2020, COVID-19 - 09-2020, COVID-19 - 01-16-2020, COVID-19 - 03-31-2020, COVID-19 -04-01-2020, COVID-19 - Directive Reporting Testing Data on Portal - 04-03-2020, COVID-19 - TB Testing Deferment - 04-44-2020, COVID-19 - 04-20-2020 , COVID-19 - 05-06-2020, COVID-19 - Menthol - 06-17-2020, COVID-19 - Antibody Testing - 07-02-2020, COVID-19 - NIH Summary - 07-28-2020, COVID-19 - Rapid Antigen Tests - 10-16-2020, COVID-19 - Crisis Staffing Tiers - 11-19-2020, COVID-19 - 12-03-2020, COVID-19 - Pfizer Vaccine Training Series For Clinicians, COVID-19 - 12-21-2020, COVID-19 - Phase 1 A - 12-21-2020 , COVID-19 - Releases Clinical Guidance Following VaST Technical Report - 06-25-2021, COVID-19 - 432 MIS-C Associated With COVID - 05-14-2020.All 2021 HAN Alerts ( Except December)
Wound Botulizm - 01-12-2021, COVID-19 Non-Hospital Therapeutics Admin Application - 01-21-2021, Wound Botulism - 01-21-2021, COVID-19 Pediatric Covid Testing - 02-01-2021, Advisory Requirements For TB Testing Of HCW Resumes - 04-01-2021, COVID-19 Vaccine Eligibility - 06-04-2021, COVID-19 Pause in J&J Distribution - 04-13-2021, COVID-19 Third Dose FOr Immunocompromised - 04-16-2021, NMMAT Pfizer Vaccine Recommendation 12 Years and Older - 05-13-2021, COVID-19 VaST Technical Report - 06-24-2021, Sodium Citate Lab Tube Shortage - 06-06-2021, COVID-19 Vaccine Data Improvement - 06-13-2021, COVID-19 Clinical Guidance Myocarditis Following mRNA Vaccination - 06-25-2021, RSV Surveillance - 07-22-2021, COVID-19 No Boosters Yet - 08-03-2021, COVID-19 Invermectin Toxicity - 09-10-2021.December 2022 HAN Alerts
CDC 00438 - 12-17-2021, Shigella In Metro Homeless - 12-16-2021, COVID-19 Boosters for 16-17 - 12-09-2021, COVID-19 Evusheld - mAb - 12-08-2021, COVID-19 CDC 459 Varient Of Concern Identified - Omicron - 12-01-2021.January 2022 HAN Alerts
Updated Guidance on Managing Healthcare Personnel with Infection or Exposure - 01-05-2022, CDC and FDA Update Indications for Pfizer-BioNTech COVID-19 Vaccine - 01-06-2022, Update on Omicron and COVID-19 Therapeutics - 01-07-2022, CDC and FDA Shorten Booster Interval for Moderna COVID-19 Vaccine - 01-10-2022, Public Health Order Enforcement to start 2/4/2022 of Up To Date Vaccination of Status - 01-14-2022, Therapeutics Update:Eligibility Criteria & Oral Antiviral & Monoclonal Antibody - 01-25-2022, Requirements on Electronic Death Certifications - 01-24-2022.